Article

Alphaeon launches interactive software platform

Alphaeon Corp. launches an innovative ophthalmology practice development platform (TouchMD) that helps specialty physicians engage patients in the education process before, during, and after the consultation.

Boston-Alphaeon Corp. launches an innovative ophthalmology practice development platform (TouchMD) that helps specialty physicians engage patients in the education process before, during, and after the consultation.

The launch is the result of a partnership formed between TouchMD and Eyemaginations. The partnership will ensure that users have access to the highest quality videos and largest library of content designed specifically for ophthalmology, according to the companies.

“TouchMD is a huge step forward in modernizing the patient education experience,” said Shareef Mahdavi, Alphaeon chief marketing officer.

"It's exciting to bring Eyemaginations [together with TouchMD], so that ophthalmologists can run more profitable practices and have more satisfied patients,” added Kary Smith, TouchMD chief executive officer.

For more articles in this issue of Ophthalmology Times’ Conference Brief, click here.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.